FDA NCTR On-Site Pathology Services

The Department of Health and Human Services Food and Drug Administration (FDA) is soliciting on-site pathology services for the National Center for Toxicological Research (NCTR) located in Jefferson, Arkansas. The contract requires a comprehensive pathology support provider capable of delivering services including necropsy, histology, clinical chemistry, immunohistochemistry, digital imaging, data management, and quality assurance for various animal species. Qualified contractors must have six primary labor categories with specific professional credentials, including a Program Director with an advanced scientific degree. The government will evaluate proposals based on past performance, with an emphasis on demonstrated experience in similar-sized scientific research support contracts. Proposals are due by May 30, 2025, with the solicitation (75F40125R00059) seeking a contractor to begin work around July 1, 2025.

The solicitation is not set aside for any specific business category and is currently performed by Toxicologic Pathology Associates, Inc. under the existing contract 75F40120C00060. The current contract has an annual obligation of approximately $4,544,195 and supports an average of 36 employees. The new contract will provide on-site pathology services in a government-furnished facility spanning approximately 23,740 square feet in Building 5B and 5D at the Jefferson Labs, with work typically structured around a five-day work week but potentially extending beyond normal hours. The labor-hour contract allows flexibility in labor mix across potentially 21 labor categories, with contractors not required to propose all categories. Potential offerors should note the contract includes provisions for medical surveillance, safety protocols, and strict compliance with OSHA and FDA guidelines.